129 related articles for article (PubMed ID: 10208458)
1. Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression.
Monnin KA; Bronstein IB; Gaffney DK; Holden JA
Hum Pathol; 1999 Apr; 30(4):384-91. PubMed ID: 10208458
[TBL] [Abstract][Full Text] [Related]
2. Expression of DNA topoisomerase I, DNA topoisomerase II-alpha, and p53 in metastatic malignant melanoma.
Lynch BJ; Komaromy-Hiller G; Bronstein IB; Holden JA
Hum Pathol; 1998 Nov; 29(11):1240-5. PubMed ID: 9824101
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.
Hafian H; Venteo L; Sukhanova A; Nabiev I; Lefevre B; Pluot M
Hum Pathol; 2004 Jun; 35(6):745-51. PubMed ID: 15188142
[TBL] [Abstract][Full Text] [Related]
4. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon.
Staley BE; Samowitz WS; Bronstein IB; Holden JA
Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499
[TBL] [Abstract][Full Text] [Related]
5. Human DNA topoisomerase I: An anticancer drug target present in human sarcomas.
Coleman LW; Rohr LR; Bronstein IB; Holden JA
Hum Pathol; 2002 Jun; 33(6):599-607. PubMed ID: 12152158
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas.
Coleman LW; Bronstein IB; Holden JA
Anticancer Res; 2001; 21(2A):1167-72. PubMed ID: 11396158
[TBL] [Abstract][Full Text] [Related]
7. Quantitative microscopy of human DNA topoisomerase II-alpha expression in transitional cell carcinoma of the bladder.
Rath-Wolfson L; Hammel I; Kugel V; Leib Z; Dekel Y; Koren R
Anal Quant Cytol Histol; 2004 Aug; 26(4):181-6. PubMed ID: 15457669
[TBL] [Abstract][Full Text] [Related]
8. The association between the p53/topoisomerase I and p53/ topoisomerase IIalpha immunophenotypes and the progression of ovarian carcinomas.
Bar JK; Grelewski P; Noga L; Rabczyński J; Gryboś M; Jeleń M
Adv Clin Exp Med; 2012; 21(1):35-42. PubMed ID: 23214297
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival.
Holden JA; Townsend JJ
Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung.
Giaccone G; van Ark-Otte J; Scagliotti G; Capranico G; van der Valk P; Rubio G; Dalesio O; Lopez R; Zunino F; Walboomers J
Biochim Biophys Acta; 1995 Dec; 1264(3):337-46. PubMed ID: 8547322
[TBL] [Abstract][Full Text] [Related]
11. Expression of DNA topoisomerase I in neoplasms of the kidney: correlation with histological grade, proliferation, and patient survival.
Gupta D; Bronstein IB; Holden JA
Hum Pathol; 2000 Feb; 31(2):214-9. PubMed ID: 10685636
[TBL] [Abstract][Full Text] [Related]
12. p53 dependence of topoisomerase I recruitment in vivo.
Mao Y; Okada S; Chang LS; Muller MT
Cancer Res; 2000 Aug; 60(16):4538-43. PubMed ID: 10969804
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate.
Willman JH; Holden JA
Prostate; 2000 Mar; 42(4):280-6. PubMed ID: 10679757
[TBL] [Abstract][Full Text] [Related]
14. Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer.
Lynch BJ; Guinee DG; Holden JA
Hum Pathol; 1997 Oct; 28(10):1180-8. PubMed ID: 9343325
[TBL] [Abstract][Full Text] [Related]
15. Expression of DNA topoisomerase IIalpha in thyroid neoplasia.
Lee A; LiVolsi VA; Baloch ZW
Mod Pathol; 2000 Apr; 13(4):396-400. PubMed ID: 10786805
[TBL] [Abstract][Full Text] [Related]
16. Expression of topoisomerase II alpha, ki67, and p53 in primary non-muscle-invasive urothelial bladder carcinoma.
Ben Abdelkrim S; Rammeh S; Ziadi S; Tlili T; Jaidane M; Mokni M
J Immunoassay Immunochem; 2014; 35(4):358-67. PubMed ID: 24624938
[TBL] [Abstract][Full Text] [Related]
17. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 protein in transitional cell carcinoma of the bladder in correlation to DNA ploidy and pathohistological stage and grade.
al-Abadi H; Nagel R; Neuhaus P
Cancer Detect Prev; 1998; 22(1):43-50. PubMed ID: 9466048
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas.
Koshiyama M; Fujii H; Kinezaki M; Yoshida M
Anticancer Res; 2001; 21(2A):905-10. PubMed ID: 11396183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
